The Relationship Between Prostacyclin Activity and Pressure in the Portal Vein
β Scribed by George Hamilton; Rose Chow Fung Phing; Ronald A. Hutton; Paresh Dandona; Kenneth E. F. Hobbs
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 553 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
The effect of portal hypertension (induced by partial ligation) on the ability of the portal vein wall to produce prostacyclin (PG12) was studied in rats over a period of 6 weeks. PG12-like activity measured by bioassay was shown to be significantly increased in portal vein segments during established hypertension when compared to control groups. As a collateral circulation developed with consequent fall in portal venous pressure, PGIz -like activity decreased. A positive correlation between PGL-like activity and portal pressure has been demonstrated. Parallel measurements of this activity by bioassay and radioimmunoassay to 6-keto-prostaglandin-F1 a showed a positive correlation (r = 0.88) and suggested that PGIz is the inhibitory prostaglandin involved. The possible significance of these observations in relation to the hemorrhagic manifestations associated with portal hypertension in man is discussed.
Prostacyclin (PG12) is a potent vasodilator and inhibitor of platelet aggregation. It is produced by vascular endothelium of many species including the rat and man (1,2). As well as being an important mediator of plateletvessel wall interaction, it may be a circulating hormone, one of the functions of which is to counteract the proaggregatory property of thromboxane, a prostaglandin derivative generated endogenously in stimulated platelets (3) (Figure 1).
The demonstration of alteration in PGI:! stimulating or inhibiting activity of plasma from patients with a number of diseases associated with hemorrhage or thrombotic complications suggests the possibility that PGIz has some clinical relevance (4). Van Hoof et al. have reported groups of patients with liver or renal disease having raised levels of PGIz stimulating factors in their plasma (5). Pace-Asciak et al. found increased PGIz activity in aortas of spontaneously hypertensive rats, and suggested that this might be an adaptive response to hypertension (6). We have demonstrated significantly greater PGI:! activity in rat portal vein wall 1 week after partial ligation of the vein sufficient to induce hypertension (7).
These observations led us to postulate that increased production of PGIz by portal vein wall in response to ~
π SIMILAR VOLUMES
The temporal relationship between intraocular pressure and extraocular muscle activation was studied in cats in response to the administration of the depolarizing muscle relaxant, succinylcholine (i.e. bolus doses of 0.1 and 1.0 mg/kg). Simultaneous changes in intraocular pressure, extraocular muscl
Vasodilation due to impaired vascular tone is common in liver failure. Vasoconstrictor drugs are almost always required during the anhepatic phase of a liver transplant to maintain blood pressure unless venovenous bypass is employed. Arginine-vasopressin can be used as a vasoconstrictor instead of o
The purpose of this study is to describe a phenomenon of bidirectional flow, "bicolor portal vein" (BPV), within the right anterior branch of the portal vein (RAPV), with color Doppler imaging (CDI). We prospectively studied with CDI the intrahepatic portal vein and its branches in 316 consecutive p
The purpose of this research was to study the efficacy and outcomes of transjugular intrahepatic shunt (TIPS) in end-stage liver disease (ESLD) patients with portal vein thrombosis (PVT) eligible for orthotopic liver transplant. Nine consecutive patients with PVT underwent TIPS as a nonemergent elec